Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 laser vs heparin sodium for xanthelasma of the eyelid
ChiCTR2500098122Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of heparin in Xanthelasma palpebrarum (XP) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Treatment effects. Started Jan 2023; status: completed.
02
Drugs
heparin
03
Conditions
Xanthelasma palpebrarum (XP)
Beyond the preview
Go deeper on ChiCTR2500098122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098122.